ArticleDiscover oncology2025
Lactylation modification regulates acute myeloid leukemia pathogenesis and immune microenvironment.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integrative profiling of lactylation reveals prognostic biomarkers and an immunosuppressive niche in acute myeloid leukemia.Frontiers in immunology · 2026Article
- Lactylation in cancer: mechanistic insights, tumor microenvironment, and therapeutic horizons.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute myeloid leukemia (AML) is a complex hematological malignancy with high mortality, particularly in the elderly. Current treatments, including chemotherapy, targeted therapies, and emerging immunotherapies such as T cell engager (TCE) and CAR-T, face challenges such as drug resistance. Lactylation, a novel post-translational modification, has emerged as a potential regulator of cellular activities and may play a role in AML pathogenesis.
methodsThis study integrated data from three GEO datasets (GSE9476, GSE37642, GSE114868) and single-cell RNA sequencing (scRNAseq) data from GSE235857. Data preprocessing involved normalization and batch effect correction using the Seurat package in R. Cell clustering and subpopulation definition were performed using UMAP and Louvain clustering. Lactylation scores were calculated using the AddModuleScore method. Differential gene expression analysis was conducted using the limma package, and Weighted Gene Co-expression Network Analysis (WGCNA) was applied to identify gene modules related to lactylation scores. Machine learning techniques, including Least Absolute Shrinkage and Selection Operator (LASSO) regression, Support Vector Machine (SVM), and random forest, were used to screen hub genes. SHAP analysis was employed to evaluate the importance of these genes in AML diagnosis.
resultsCell clustering identified 8 clusters and 7 subpopulations. Lactylation scores were significantly lower in AML patients compared to healthy controls (P < 0.0001). Differential expression analysis revealed significant gene expression differences between AML and controls, with key genes such as KHDRBS1 and RBM17 showing high importance in AML diagnosis. Machine learning identified five hub-genes (KHDRBS1, U2AF2, RBM17, RPL14, NCL) with high predictive value. SHAP analysis confirmed the importance of these genes, with KHDRBS1 having the highest average absolute SHAP value (0.0669). Immune cell infiltration analysis showed significant differences in immune cell levels between AML patients and controls, with key genes correlating with immune cell infiltration.
conclusionLactylation is associated with AML pathogenesis and may serve as a potential biomarker for diagnosis and treatment. The identified key genes and their correlation with immune cell infiltration provide new insights into AML’s immune microenvironment and potential therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.